发布求助
文献互助 智能选刊 最新文献

The Brown University Psychopharmacology Update最新文献

筛选
英文 中文
Short-acting opioids improve outcome in hospitalized patients with OUD 短效阿片类药物改善OUD住院患者的预后
The Brown University Psychopharmacology Update Pub Date : 2026-09-02 DOI: 10.1002/pu.31499
{"title":"Short-acting opioids improve outcome in hospitalized patients with OUD","authors":"","doi":"10.1002/pu.31499","DOIUrl":"https://doi.org/10.1002/pu.31499","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148872081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semaglutide reduces craving for nicotine in Phase 2a trial Semaglutide在2a期试验中减少对尼古丁的渴望
The Brown University Psychopharmacology Update Pub Date : 2026-09-02 DOI: 10.1002/pu.31505
{"title":"Semaglutide reduces craving for nicotine in Phase 2a trial","authors":"","doi":"10.1002/pu.31505","DOIUrl":"https://doi.org/10.1002/pu.31505","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148872075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2026-09-02 DOI: 10.1002/pu.31506
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31506","DOIUrl":"https://doi.org/10.1002/pu.31506","url":null,"abstract":"<p>Fluvoxamine maleate (generic) Luvox (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 10","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148872077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31493
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31493","DOIUrl":"https://doi.org/10.1002/pu.31493","url":null,"abstract":"<p>Iloperidone (generic) Fanapt (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overprescribing and the ‘mental health crisis’: will deprescribing make America healthy again? 过度处方和“心理健康危机”：减少处方会让美国人恢复健康吗？
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31491
Lawrence H. Price M.D.
{"title":"Overprescribing and the ‘mental health crisis’: will deprescribing make America healthy again?","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31491","DOIUrl":"https://doi.org/10.1002/pu.31491","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trial suggests effectiveness of psilocybin for cocaine use disorder 试验表明裸盖菇素对可卡因使用障碍有效
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31488
{"title":"Trial suggests effectiveness of psilocybin for cocaine use disorder","authors":"","doi":"10.1002/pu.31488","DOIUrl":"https://doi.org/10.1002/pu.31488","url":null,"abstract":"<p>Individuals with cocaine use disorder who received a single dose of psilocybin combined with psychotherapy showed greater reductions in cocaine use relative to active placebo with psychotherapy, a randomized trial has found. No serious adverse events were reported during the trial.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genotype-guided SSRI prescribing might have long-term benefit 基因型导向的SSRI处方可能具有长期效益
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31489
{"title":"Genotype-guided SSRI prescribing might have long-term benefit","authors":"","doi":"10.1002/pu.31489","DOIUrl":"https://doi.org/10.1002/pu.31489","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":"6-8"},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive antipsychotics for MDD differ in efficacy and acceptability 辅助抗精神病药物治疗重度抑郁症的疗效和可接受性不同
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31485
{"title":"Adjunctive antipsychotics for MDD differ in efficacy and acceptability","authors":"","doi":"10.1002/pu.31485","DOIUrl":"https://doi.org/10.1002/pu.31485","url":null,"abstract":"<p>A systematic review and network meta-analysis has found considerable differences in efficacy and acceptability among atypical antipsychotics used as adjunctive treatment for major depressive disorder (MDD). Lumateperone had the greatest effect size for efficacy, and aripiprazole had the highest level of acceptability. Results of the systematic review and meta-analysis were published online May 6, 2026 in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New oral anticoagulants and related anxiety symptoms 新型口服抗凝剂及相关焦虑症状
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31486
Y. W. Francis Lam Pharm.D., FCCP
{"title":"New oral anticoagulants and related anxiety symptoms","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31486","DOIUrl":"https://doi.org/10.1002/pu.31486","url":null,"abstract":"<p>Newer oral anticoagulants (NOACs), now most commonly referred to as direct oral anticoagulants (DOACs), have replaced warfarin in preventing clot formation and minimizing the risk of stroke in patients with atrial fibrillation. Unlike warfarin, which exerts its anticoagulant effect indirectly by inhibiting vitamin K metabolism, DOACs have a direct anticoagulant effect via inhibition of specific coagulation factors such as activated factor II (Iia, thrombin) or activated factor X (Xa). Not only are DOACs highly effective and convenient for patients, they also do not entail the close monitoring of pharmacologic effect required with warfarin. As a result, their use is included in clinical guidelines and favored by clinicians as first-line treatment.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2026-08-03 DOI: 10.1002/pu.31493
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31493","DOIUrl":"https://doi.org/10.1002/pu.31493","url":null,"abstract":"<p>Iloperidone (generic) Fanapt (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"37 9","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148662125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书